Cleared Traditional

K152824 - MEDT PEN NEEDLE

K152824 is an FDA 510(k) clearance for MEDT PEN NEEDLE, manufactured by Shandong Caremed Medical Products Co., Ltd.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 160-day FDA review.

K152824 · Shandong Caremed Medical Products Co., Ltd. · General Hospital
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Mar 2016
Decision
160d
Days
Class 2
Risk

K152824 is an FDA 510(k) clearance for the MEDT PEN NEEDLE. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Shandong Caremed Medical Products Co., Ltd. (Heze, CN). The FDA issued a Cleared decision on March 7, 2016 after a review of 160 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K152824

510(k) Number K152824 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2015
Decision Date March 07, 2016
Days to Decision 160 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
31d slower than avg
Panel avg: 129d · This submission: 160d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Mid-Link Consulting Co, Ltd.
DIANA HONG

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 597
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K152824.
IMPROSAFE Blood Collection Set with Pre-attached Holder, IMPROVACUTER Blood Collection Set Pre-attached Holder, IMPROSAFE Blood Collection Set, IMPROVACUTER Blood Collection Set, IMPROSAFE Multi Sample Needle, IMPROSAFE Multi Sample Needle (Flashback), IMPROVACUTER Multi Sample Needle
K153388 · Guangzhou Improve Medical Instruments Co., Ltd. · Jun 2016
BD Eclipse Hypodermic Needle
K161170 · Becton, Dickinson and Company · May 2016
Sungshim Insulin Pen Needle
K152334 · Sung Shim Medicare Co., Ltd. · Mar 2016
Pencylcap
K152050 · B.Braun Melsungen AG · Mar 2016
Safe Block Pen Needle
K151311 · Artsana S.P.A · Feb 2016
Top Fine Pen Needle
K152410 · Medexel Co.,Ltd · Feb 2016